| ORIGINAL ARTICLE
|Year : 2007 | Volume
| Issue : 2 | Page : 92-95
Outcomes of renal transplantation in patients with immunoglobulin A nephropathy in India
B Chacko1, JT George1, N Neelakantan2, A Korula3, JK Chakko1
1 Department of Nephrology, Christian Medical College, Vellore-632 004, India
2 Department of Biostatistics, Christian Medical College, Vellore-632 004, India
3 Department of Pathology, Christian Medical College, Vellore-632 004, India
Background: There is a paucity of data on the course of renal transplant in patients with immunoglobulin A (IgA) nephropathy (IgAN) from India. While the natural history of IgAN in the Indian context is rapidly progressive, the post-transplant course remains speculative. Aim: To study the graft survival in renal transplant recipients whose native kidney disease was IgAN and the incidence and correlates of recurrent disease.
Settings and Designs: Retrospective case control study from a Nephrology unit of a large tertiary care center. Materials and Methods: The outcomes of 56 transplant patients (58 grafts) with biopsy-proven IgAN and of 116 patients without IgAN or diabetic nephropathy, transplanted during the same period were analyzed. Correlates of biopsy-confirmed recurrent disease were determined. Statistical Analysis: Means were analyzed by Student's t test and Mann-Whitney test; proportions were determined by Chi-square analysis and graft survival curves were generated using the Kaplan-Meier. Results: Five-year graft survival for IgA patients was not significantly different from that in the reference group (90% and 79%, P = 0.6). During a mean follow-up of 42 months (range, 1-144), 28 event graft biopsies were required in 20 grafts of IgAN. Histological recurrence was diagnosed in five of the 20 available biopsies (25%) after a mean duration of 28 months. Recurrence did not correlate with donor status, HLA B35 and A2, recipient age, gender or immunosuppression. Conclusions: Renal transplantation is an appropriate treatment modality for IgA nephropathy patients with end-stage renal disease in India, despite the potential for recurrent disease. The posttransplant course is an indolent one when compared to the malignant pretransplant phase.
J K Chakko
Department of Nephrology, Christian Medical College, Vellore-632 004
Source of Support: None, Conflict of Interest: None
[FULL TEXT] [PDF]*